Primary Care Gender Affirming Hormone Therapy Initiation Guidelines
Released in March 2023 to support primary care clinicians to initiate gender affirming hormone therapy (GAHT) for adults in a primary care setting.
Download the guidelines here (latest version 29/3/23)
Primary Care GAHT Guidelines_Web_29 Mar
Endorsed by RNZCGP: The Royal New Zealand College of General Practitioners
Individual documents from the guideline
Patient information sheets:
Primary Care GAHT Guidelines_Patient information sheet_Oestrogen
Primary Care GAHT Guidelines_Patient information sheet_Testosterone
Injection guidance for health professionals:
Primary Care GAHT Guidelines_Testosterone Administration
Updated guidelines for gender affirming healthcare in Aotearoa 2025
National guidelines for gender affirming care in Aotearoa can be found here:
https://patha.nz/resources-and-training/clinical-guidelines
Trans health peer support for GPs and NPs in Aotearoa:
- Gender affirming care advice & support for prescribers – please email gaht@qtopia.org.nz. This email is managed by GP specialists in gender affirming healthcare.
- Trans health GP and NP peer group (meets on zoom) – email gaht@qtopia.org.nz to join
- GAHT prescriber training details here: https://primarycare.qtopia.org.nz/
- Join the Professional Association for Transgender Health Aotearoa (PATHA)
The following information sheets have been made to support healthcare professionals but are not part of the above guidelines:
A summary of the evidence and risks of using progesterone as part of E-GAHT – written for patients but shared here for clinicians to use if useful:
Progesterone patient info sheet for people taking E-GAHT
The primary care guidelines do not include oestrogen or testosterone gel as these were funded after the guidelines were developed. Information about prescribing these can be found here:
https://patha.nz/resources-and-training/clinical-guidelines
https://healthify.nz/medicines-a-z/o/oestrogen-gender-affirming-hormone-therapy
https://healthify.nz/medicines-a-z/t/testosterone-gender-affirming-hormone-therapy
